We narrowed to 4,264 results for: DME

1. I165L

   Plasmid

   #184301

   Purpose

   To study dynamics of G-actin using NMR spectroscopy.

   Depositor

   Michael Rosen

   Article

   Ali et al Nat Struct Mol Biol. 2022 Apr;29(4):320-

   Insert

   Act5C (Act5C Fly)
   

   Tags

   B-Thymosin followedby hexahistidine tag

   Expression

   Yeast

   Mutation

   I165L

   Promoter

   AOX1

   Available Since

   May 19, 2022

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

2. I329L

   Plasmid

   #184312

   Purpose

   To study dynamics of G-actin using NMR spectroscopy.

   Depositor

   Michael Rosen

   Article

   Ali et al Nat Struct Mol Biol. 2022 Apr;29(4):320-

   Insert

   Act5C (Act5C Fly)
   

   Tags

   B-Thymosin followedby hexahistidine tag

   Expression

   Yeast

   Mutation

   I329L

   Promoter

   AOX1

   Available Since

   May 19, 2022

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

3. I341L

   Plasmid

   #184313

   Purpose

   To study dynamics of G-actin using NMR spectroscopy.

   Depositor

   Michael Rosen

   Article

   Ali et al Nat Struct Mol Biol. 2022 Apr;29(4):320-

   Insert

   Act5C (Act5C Fly)
   

   Tags

   B-Thymosin followedby hexahistidine tag

   Expression

   Yeast

   Mutation

   I341L

   Promoter

   AOX1

   Available Since

   May 19, 2022

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

4. I34L

   Plasmid

   #184296

   Purpose

   To study dynamics of G-actin using NMR spectroscopy.

   Depositor

   Michael Rosen

   Article

   Ali et al Nat Struct Mol Biol. 2022 Apr;29(4):320-

   Insert

   Act5C (Act5C Fly)
   

   Tags

   B-Thymosin followedby hexahistidine tag

   Expression

   Yeast

   Mutation

   I34L

   Promoter

   AOX1

   Available Since

   May 19, 2022

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

5. I208L

   Plasmid

   #184303

   Purpose

   To study dynamics of G-actin using NMR spectroscopy.

   Depositor

   Michael Rosen

   Article

   Ali et al Nat Struct Mol Biol. 2022 Apr;29(4):320-

   Insert

   Act5C (Act5C Fly)
   

   Tags

   B-Thymosin followedby hexahistidine tag

   Expression

   Yeast

   Mutation

   I208L

   Promoter

   AOX1

   Available Since

   May 19, 2022

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

6. I250L

   Plasmid

   #184306

   Purpose

   To study dynamics of G-actin using NMR spectroscopy.

   Depositor

   Michael Rosen

   Article

   Ali et al Nat Struct Mol Biol. 2022 Apr;29(4):320-

   Insert

   Act5C (Act5C Fly)
   

   Tags

   B-Thymosin followedby hexahistidine tag

   Expression

   Yeast

   Mutation

   I250L

   Promoter

   AOX1

   Available Since

   May 19, 2022

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

7. I248L

   Plasmid

   #184305

   Purpose

   To study dynamics of G-actin using NMR spectroscopy.

   Depositor

   Michael Rosen

   Article

   Ali et al Nat Struct Mol Biol. 2022 Apr;29(4):320-

   Insert

   Act5C (Act5C Fly)
   

   Tags

   B-Thymosin followedby hexahistidine tag

   Expression

   Yeast

   Mutation

   I248L

   Promoter

   AOX1

   Available Since

   May 19, 2022

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

8. I64L

   Plasmid

   #184321

   Purpose

   To study dynamics of G-actin using NMR spectroscopy.

   Depositor

   Michael Rosen

   Article

   Ali et al Nat Struct Mol Biol. 2022 Apr;29(4):320-

   Insert

   Act5C (Act5C Fly)
   

   Tags

   Hexahistidine followed by B-thymosin

   Expression

   Yeast

   Mutation

   I64L

   Promoter

   AOX1

   Available Since

   May 19, 2022

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

9. I192L

   Plasmid

   #184302

   Purpose

   To study dynamics of G-actin using NMR spectroscopy.

   Depositor

   Michael Rosen

   Article

   Ali et al Nat Struct Mol Biol. 2022 Apr;29(4):320-

   Insert

   Act5C (Act5C Fly)
   

   Tags

   B-Thymosin followedby hexahistidine tag

   Expression

   Yeast

   Mutation

   I192L

   Promoter

   AOX1

   Available Since

   May 19, 2022

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

10. I71L

    Plasmid

    #184297

    Purpose

    To study dynamics of G-actin using NMR spectroscopy.

    Depositor

    Michael Rosen

    Article

    Ali et al Nat Struct Mol Biol. 2022 Apr;29(4):320-

    Insert

    Act5C (Act5C Fly)
    

    Tags

    B-Thymosin followedby hexahistidine tag

    Expression

    Yeast

    Mutation

    I71L

    Promoter

    AOX1

    Available Since

    May 18, 2022

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

11. pnEA-vH_His-TEV-DSep1-msfGFP

    Plasmid

    #174494

    Purpose

    bacterial expression of Drosophila Sep1 fused to monomeric superfolder GFP

    Depositor

    Manos Mavrakis

    Article

    Iv et al J Cell Sci. 2021 Jul 8. pii: 270842. doi

    Insert

    Sep1 (Sep1 Fly)
    

    Tags

    His6-TEV and msfGFP

    Expression

    Bacterial

    Available Since

    Nov. 23, 2021

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

12. pDONR221-SLC2A13_STOP

    Plasmid

    #161316

    Purpose

    Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

    Depositor

    RESOLUTE Consortium, Giulio Superti-Furga

    Article

    Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

    Insert

    SLC2A13 (SLC2A13 Human)
    

    Expression

    Mammalian

    Available Since

    Oct. 15, 2021

    Availability

    Industry, Academic Institutions, and Nonprofits

    

    Enlarge

13. pDONR221-SLC35F1_STOP

    Plasmid

    #161299

    Purpose

    Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

    Depositor

    RESOLUTE Consortium, Giulio Superti-Furga

    Article

    Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

    Insert

    SLC35F1 (SLC35F1 Human)
    

    Expression

    Mammalian

    Available Since

    Oct. 15, 2021

    Availability

    Industry, Academic Institutions, and Nonprofits

    

    Enlarge

14. pDONR221-SLC35E3_STOP

    Plasmid

    #161228

    Purpose

    Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

    Depositor

    RESOLUTE Consortium, Giulio Superti-Furga

    Article

    Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

    Insert

    SLC35E3 (SLC35E3 Human)
    

    Expression

    Mammalian

    Available Since

    Sept. 15, 2021

    Availability

    Industry, Academic Institutions, and Nonprofits

    

    Enlarge

15. pDONR221-SLC2A12_STOP

    Plasmid

    #161233

    Purpose

    Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

    Depositor

    RESOLUTE Consortium, Giulio Superti-Furga

    Article

    Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

    Insert

    SLC2A12 (SLC2A12 Human)
    

    Expression

    Mammalian

    Available Since

    Sept. 15, 2021

    Availability

    Industry, Academic Institutions, and Nonprofits

    

    Enlarge

16. pDONR221-SLC35D3_STOP

    Plasmid

    #161276

    Purpose

    Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

    Depositor

    RESOLUTE Consortium, Giulio Superti-Furga

    Article

    Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

    Insert

    SLC35D3 (SLC35D3 Human)
    

    Expression

    Mammalian

    Available Since

    Sept. 15, 2021

    Availability

    Industry, Academic Institutions, and Nonprofits

    

    Enlarge

17. pDONR221-SLC41A2_STOP

    Plasmid

    #161320

    Purpose

    Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

    Depositor

    RESOLUTE Consortium, Giulio Superti-Furga

    Article

    Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

    Insert

    SLC41A2 (SLC41A2 Human)
    

    Expression

    Mammalian

    Available Since

    Sept. 15, 2021

    Availability

    Industry, Academic Institutions, and Nonprofits

    

    Enlarge

18. pDONR221-SLC4A5_STOP

    Plasmid

    #161450

    Purpose

    Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

    Depositor

    RESOLUTE Consortium, Giulio Superti-Furga

    Article

    Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

    Insert

    SLC4A5 (SLC4A5 Human)
    

    Expression

    Mammalian

    Available Since

    Sept. 15, 2021

    Availability

    Industry, Academic Institutions, and Nonprofits

    

    Enlarge

19. pDONR221-TMEM104_STOP

    Plasmid

    #161428

    Purpose

    Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

    Depositor

    RESOLUTE Consortium, Giulio Superti-Furga

    Article

    Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

    Insert

    TMEM104 (TMEM104 Human)
    

    Expression

    Mammalian

    Available Since

    Sept. 15, 2021

    Availability

    Industry, Academic Institutions, and Nonprofits

    

    Enlarge

20. pDONR221-SLC31A1_STOP

    Plasmid

    #161418

    Purpose

    Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

    Depositor

    RESOLUTE Consortium, Giulio Superti-Furga

    Article

    Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

    Insert

    SLC31A1 (SLC31A1 Human)
    

    Expression

    Mammalian

    Available Since

    Sept. 15, 2021

    Availability

    Industry, Academic Institutions, and Nonprofits

    

    Enlarge